BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26232617)

  • 1. Involvement of miR-34c in high glucose-insulted mesenchymal stem cells leads to inefficient therapeutic effect on myocardial infarction.
    Kang HJ; Kang WS; Hong MH; Choe N; Kook H; Jeong HC; Kang J; Hur J; Jeong MH; Kim YS; Ahn Y
    Cell Signal; 2015 Nov; 27(11):2241-51. PubMed ID: 26232617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
    Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
    Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice.
    Fujii H; Sun Z; Li SH; Wu J; Fazel S; Weisel RD; Rakowski H; Lindner J; Li RK
    JACC Cardiovasc Imaging; 2009 Jul; 2(7):869-79. PubMed ID: 19608138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis following cell injection is induced by an excess inflammatory response coordinated by bone marrow cells.
    Hattori H; Amano Y; Habu-Ogawa Y; Ando T; Takase B; Ishihara M
    Cell Transplant; 2013; 22(12):2381-92. PubMed ID: 23146336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
    Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
    Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease.
    Xu Q; Seeger FH; Castillo J; Iekushi K; Boon RA; Farcas R; Manavski Y; Li YG; Assmus B; Zeiher AM; Dimmeler S
    J Am Coll Cardiol; 2012 Jun; 59(23):2107-17. PubMed ID: 22651868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-92a regulates angiogenic activity of adipose-derived mesenchymal stromal cells.
    Kalinina N; Klink G; Glukhanyuk E; Lopatina T; Efimenko A; Akopyan Z; Tkachuk V
    Exp Cell Res; 2015 Nov; 339(1):61-6. PubMed ID: 26477824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
    Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
    Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimization of cell therapy by combinational application with apicidin-treated mesenchymal stem cells after myocardial infarction.
    Cho DI; Kang WS; Hong MH; Kang HJ; Kim MR; Kim MC; Kim YS; Ahn Y
    Oncotarget; 2017 Jul; 8(27):44281-44294. PubMed ID: 28498815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a.
    Yu S; Hong Q; Wang Y; Hou K; Wang L; Zhang Y; Fu B; Zhou Y; Zheng W; Chen X; Wu D
    Circ J; 2015; 79(11):2487-98. PubMed ID: 26299712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival.
    Spiegelstein D; Kim C; Zhang Y; Li G; Weisel RD; Li RK; Yau TM
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3311-6. PubMed ID: 17827264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor-AB promotes the generation of adult bone marrow-derived cardiac myocytes.
    Xaymardan M; Tang L; Zagreda L; Pallante B; Zheng J; Chazen JL; Chin A; Duignan I; Nahirney P; Rafii S; Mikawa T; Edelberg JM
    Circ Res; 2004 Mar; 94(5):E39-45. PubMed ID: 14963008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial injection of apelin-overexpressing bone marrow cells improves cardiac repair via upregulation of Sirt3 after myocardial infarction.
    Li L; Zeng H; Hou X; He X; Chen JX
    PLoS One; 2013; 8(9):e71041. PubMed ID: 24039710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent distention of colon damages interstitial cells of Cajal through Ca
    Yang S; Dong F; Li D; Sun H; Wu B; Sun T; Wang Y; Shen P; Ji F; Zhou D
    J Cell Mol Med; 2017 Sep; 21(9):1881-1892. PubMed ID: 28580775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose impairs angiogenesis and promotes ventricular remodelling following myocardial infarction via upregulation of microRNA-17.
    Yan M; Chen K; Sun R; Lin K; Qian X; Yuan M; Wang Y; Ma J; Qing Y; Xu J; Wei M; Huang D; Li J
    Exp Cell Res; 2019 Aug; 381(2):191-200. PubMed ID: 31075259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous miRNA-146a Enhances the Therapeutic Efficacy of Human Mesenchymal Stem Cells by Increasing Vascular Endothelial Growth Factor Secretion in the Ischemia/Reperfusion-Injured Heart.
    Seo HH; Lee SY; Lee CY; Kim R; Kim P; Oh S; Lee H; Lee MY; Kim J; Kim LK; Hwang KC; Chang W
    J Vasc Res; 2017; 54(2):100-108. PubMed ID: 28407626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cardiac microRNAs by bone marrow mononuclear cell therapy in myocardial infarction.
    Iekushi K; Seeger F; Assmus B; Zeiher AM; Dimmeler S
    Circulation; 2012 Apr; 125(14):1765-73, S1-7. PubMed ID: 22403243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.